United States · Biotechnology startup
United States · AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics.
Funding reportedLast round: Post-IPO Debt
What company datasets say AbbVie raised
Funding, as reported
Reported in all$8.0Bin dollars
Last roundPost-IPO Debt
SEC Form D$3.8B sold, 1 filing, last May 2016
Founders and team
From the SEC filings it signed: 9 on the team.
- Azita J. Saleki-GerhardtExecutive Officeri
- Carlos E. AlbanExecutive Officeri
- Henry E. GosebruchExecutive Officeri
- Laura J. SchumacherExecutive Officeri
- Michael E. SeverinoExecutive Officeri
- Richard A. GonzalezExecutive Officer, Directori
- Thomas A. HurwichExecutive Officeri
- Timothy J. RichmondExecutive Officeri
- William J. ChaseExecutive Officeri
On the board, as filediBrett J. HartEdward J. RappEdward M. LiddyFrederick H. WaddellGlenn F. TiltonRobert J. AlpernRoxanne S. AustinWilliam H.L. Burnside
On 2 portfolio pages
Investors who name them
Each firm lists AbbVie on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Apogee TherapeuticsSan Francisco · founded 2022
Is this your company?
Add your raise, your deck and your story, and put AbbVie in front of investors. Or tell us what we have wrong.